HighTower Advisors’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,016
Closed -$20K 3994
2024
Q3
$20K Hold
2,016
﹤0.01% 3511
2024
Q2
$31K Hold
2,016
﹤0.01% 3364
2024
Q1
$44K Hold
2,016
﹤0.01% 3269
2023
Q4
$39K Hold
2,016
﹤0.01% 3338
2023
Q3
$37K Hold
2,016
﹤0.01% 3260
2023
Q2
$37K Hold
2,016
﹤0.01% 3199
2023
Q1
$58K Hold
2,016
﹤0.01% 3031
2022
Q4
$56K Hold
2,016
﹤0.01% 3013
2022
Q3
$111K Buy
+2,016
New +$111K ﹤0.01% 2750

Other funds holding OPTN

HighTower Advisors's OPTN Position: Q4 2024 in Review

HighTower Advisors sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 2,016 shares — an estimated $20K sold.

HighTower Advisors first reported a position in OPTN in Q3 2022 and held it in 9 quarters. The position peaked at $111K in Q3 2022. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • HighTower Advisors reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • HighTower Advisors sold 2,016 OptiNose shares in Q4 2024, an estimated $20K.
  • HighTower Advisors first reported a position in OptiNose in Q3 2022 and held it in 9 quarters.
  • HighTower Advisors's OptiNose position peaked at $111K in Q3 2022.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on HighTower Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.